| Model Number |
6996SQ58 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Endocarditis (1834); Blister (4537); Swelling/ Edema (4577); Bacteremia (4846)
|
| Date of Event |
02/01/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: mc2vr01 ipg implanted: (b)(6) 2024.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately three months post implant, the patient experienced serratia bacteremia and was treated with antibiotics.Approximately two months later, the patient experienced swelling and a large blister at the device site.The patient also experienced endocarditis.The patient was treated with antibiotics and the implantable cardioverter defibrillator (icd) system was explanted.A previously abandoned leadless pacemaker was reactivated and remains in use.No further patient complications have been reported as a result of this event.
|
| |
|
Search Alerts/Recalls
|